Showing results (91-100 of 51,765) with videos related to

Sort By:
Pageof 5,177
Journal of Analytical Toxicology|April 13, 2001
Cobas Mira S endpoint enzymatic assay for plasma formateB Blomme, P Lheureux, E Gerlo, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2020
PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage RepairPanagiotis A Konstantinopoulos, Stephanie Lheureux, Kathleen N Moore
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
DNA Methylation as a Robust Classifier of Epithelial Ovarian CancerCharles A Ishak, Stephanie Lheureux, Daniel D De Carvalho
Human & Experimental Toxicology|March 1, 1990
Zolpidem intoxication mimicking narcotic overdose: response to flumazenilP Lheureux, G Debailleul, O De Witte, et al.
Expert Opinion on Drug Safety|June 9, 2015
Safety evaluation of olaparib for treating ovarian cancerStephanie Lheureux, Valerie Bowering, Katherine Karakasis, et al.
Biochemical and Biophysical Research Communications|July 18, 1997
Overexpression of a 40-kDa protein in human multidrug resistant cellsY Wang, X Q Pan, F Lheureux, et al.
Lancet (London, England)|March 27, 2019
Epithelial ovarian cancerStephanie Lheureux, Charlie Gourley, Ignace Vergote, et al.
Inorganic Chemistry|August 28, 2014
High-pressure Raman scattering of CaWO₄ up to 46.3 GPa: evidence of a new high-pressure phasePablo Botella, Raúl Lacomba-Perales, Daniel Errandonea, et al.
Journal of Synchrotron Radiation|August 22, 2001
EXAFS study on liquid gallium under high pressure and high temperatureL Comez, A Di Cicco, M Minicucci, et al.
Cancers|March 10, 2022
Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic CancersLawrence Kasherman, Shiru Lucy Liu, Katherine Karakasis, et al.
Pageof 5,177